News

A growing list of industry experts have signed up to join the speaker panel at Lonza’s 2nd Global Endotoxin Testing Summit from 23-25 May 2016, Annapolis, MD, and Pickering Beach, DE (USA).

HRH Duke of York recently discovered how Blueberry Therapeutics is set to create safe, effective “nanomedicines” to treat a number of unmet clinical needs.

Chem-space.com online searchable marketplace features over 15 million compounds.

Walter Reed Army Institute of Research (WRAIR) researchers recently published the results of testing a Plasmodium vivax malaria vaccine candidate in a human challenge model.

X-ray crystallography provides drug template against disease transmitted by small rodents.

Lower oxygen intake could be used to prevent mitochondrial diseases from forming.

Experts at the University of Pittsburgh have used gene therapy to relieve the symptoms of tremor and mobility impairment in patients with Parkinson’s disease.

Company has signed the agreement with ECFP to advance research into the biophysical properties of Lamellasome for bespoke purposes.

Envigo is pleased to announce that Krishnan Kolappaswamy, DVM, DACLAM, Ph.D., Associate Director, Laboratory Animal Medicine-North America, has been appointed to the editorial board of Lab Animal Journal. Dr. Kolappaswamy joins other highly acclaimed scientists and veterinarians on the publication’s editorial board.

The company is launching its unique platform to generate transmembrane peptides with the ability to disrupt dimerization of target receptors.